Stock Ticker

  • Loading stock data...

New Momentum Shows Up in Healthcare Logistics: SYK, IVST, and EW

The action across the market has been a roller coaster over the past two months. With the Fed setting up to raise rates again in December and little chance of a trade deal with China in the works before year-end, investors are looking for a port in the storm. The healthcare logistics and supply space […]

Goldman Sachs Group Inc (NYSE:GS) Key Takeaways from Transcatheter Cardiovascular Therapeutics Conference

Boston, MA 09/16/2014 (wallstreetpr) – Investment advisor, Goldman Sachs Group Inc (NYSE:GS) analysts have provided key takeaways from the 2014 Transcatheter Cardiovascular Therapeutics or TPT conference. Accordingly, they have retained their Buy rating on the shares of Abbott Pharmaceuticals (NYSE:ABT) and Edwards Lifesciences Corp (NYSE:EW) while they remained Neutral on St. Jude Medical, Inc. (NYSE:STJ) […]

Goldman Sachs Group Inc (NYSE:GS) Sees More Clarity On Edwards Lifesciences Corp (NYSE:EW) Outlook After SAPIEN XT Approval

Boston, MA 06/18/2014 (wallstreetpr) – Investment brokerage Goldman Sachs Group Inc (NYSE:GS) sees more clarity on the outlook of the medical technology company Edwards Lifesciences Corp (NYSE:EW) after the company has received approval from the Food and Drug Administration or FDA for SAPIEN XT, its next generation product of trans catheter aortic valve replacement or […]

Medtronic, Inc. (NYSE:MDT) Settles Fight for Heart Valve Patent with Rival Edwards

Boston, MA 05/22/2014 (wallstreetpr) – The patent litigation was settled between rivals Medtronic, Inc. (NYSE:MDT) and Edwards Lifesciences Corp (NYSE:EW). Medtronic agreed to pay around $1 billion to its rival for settling this litigation. This also allowed Medtronic to keep the CoreValve artificial heart valve in the United States market. The announcement for the settlement […]

Medtronic, Inc. (NYSE:MDT) To Benefit From Use Of Artificial Valves

Boston, MA 04/08/2014 (wallstreetpr) – Medtronic, Inc. (NYSE:MDT) stocks could see a significant uptick after recent studies were released to show that the new range of artificial valves could see significant usage increase as procedures and valves are being used in a way that they can be inserted into the heart without making major surgical procedures […]

Move over heart surgery- Edward’s Sapien device is here!

Boston, MA 03/12/2013 (wallstreetpr) – The Sapien device manufactured by Edwards Lifesciences Corp (NYSE:EW) is as effective and safe as an open heart surgery and has the capacity to last for at least three years say researchers. This device is implanted in the heart to fix a diseased aortic valve and a catheter is used […]

Sign Up To Get Our Latest Stocks Alerts